NSCI — Nanalysis Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual cashflow statement for Nanalysis Scientific, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	C2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1.77	-9.91	-16.8	-13.6	-5.66
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.569	1.86	3.87	11.1	1.02
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2.56	-4.41	-2.92	1.26	4.7
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-1.2	-8.55	-11.2	3.26	3.45
Capital Expenditures	-3	-7.2	-4.59	-1.86	-1.88
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.343	-4.29	-1.46	0.168	0.105
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-3.35	-11.5	-6.06	-1.69	-1.78
Financing Cash Flow Items	10.2	13.8	2.88	3.21	1.52
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11.8	13.2	14.5	-0.956	0.109
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7.25	-6.88	-2.77	0.617	1.78